Top compounds associated with response to SLC25A23


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus FIMM pan-cancer AAC -0.44 0.006
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.006
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.007
mRNA nelarabine CTRPv2 pan-cancer AAC -0.1 0.009
mRNA A-770041 GDSC1000 pan-cancer AAC 0.13 0.01
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.088 0.01
mRNA YL54 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.13 0.01
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.083 0.01
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.091 0.01
Download CSV